Finanzwire Finanzwire
Basculer en Français
10700 Companies
228730 Keywords
157366 Articles
121425 Press releases
Headlines Articles Press releases Nemysis Limited Remove
  1. Home
  2. Companies
  3. Nemysis Limited
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 05/23/2024 at 10:05, 2 years 1 month ago

    Nemysis Limited Announces the Grant of Further IP for its IHAT Oral Iron Supplement

    Nutritional Supplement IHAT Patent Iron Deficiency Nemysis Limited
  • PRESS RELEASE

    published on 05/23/2024 at 10:00, 2 years 1 month ago

    Nemysis Limited Announces the Grant of Further IP for its IHAT Oral Iron Supplement

    Nemysis strengthens IP portfolio with new patent (WO2021204705) for IHAT oral iron supplement, safe for iron deficiency treatment. Dr. Comelli and Dr. Faria comment on significance
    IHAT Patent IP Portfolio Iron Deficiency Nemysis
    Logo of Nemysis Limited
  • PRESS RELEASE

    published on 01/10/2024 at 17:00, 2 years 5 months ago

    Nemysis Limited Signs With Kolinpharma SpA an IHAT Sales and Marketing Agreement

    Nemysis Ltd and Kolinpharma® SpA have signed a non-exclusive sales and marketing agreement for IHAT (Iron Hydroxide Adipate Tartrate), Nemysis' innovative oral iron supplementation product. This partnership aims to enhance coverage of the target markets within Italy, one of the largest in Europe, and improve access to effective iron deficiency solutions.
    Nemysis Ltd Kolinpharma® SpA IHAT Iron Supplementation Italy Market
    Logo of Nemysis Limited
Accesswire
  • Published on 07/08/2026 at 16:45, 3 hours 25 minutes ago

    Change Of Record Date for Special Meeting

  • Published on 07/08/2026 at 15:25, 4 hours 45 minutes ago

    Rockhaven Announces Granting of Incentive Stock Options

  • Published on 07/08/2026 at 15:00, 5 hours 10 minutes ago

    Karbon-X Announces Strategic Partnership to Evaluate Kenya BioHub Initiative

  • Published on 07/08/2026 at 15:00, 5 hours 10 minutes ago

    GameSquare's Stream Hatchet Publishes Esports Live Streaming Trends Report

  • Published on 07/08/2026 at 14:30, 5 hours 40 minutes ago

    Research Analyst Report on NanoViricides Rates Company "Outperform"; Separately, A "Fireside Chat" Interview of the Company's President Dr. Anil Diwan Hosted by Mr. Dave Donlin was Published by StockInvestor Daily

View all ACCESSWIRE
EQS Group
  • Published on 07/08/2026 at 19:45, 24 minutes ago

    NNS acquires shares in OCI

  • Published on 07/08/2026 at 19:42, 27 minutes ago

    EQS-Adhoc: SMAG Mobile Antenna Masts AG sets final offer price for initial public offering (IPO) at EUR 46 per share

  • Published on 07/08/2026 at 18:45, 1 hour 24 minutes ago

    EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma publishes preliminary Q3 key figures and raises 2026 revenue and earnings guidance

  • Published on 07/08/2026 at 18:17, 1 hour 52 minutes ago

    Dividend announcement

  • Published on 07/08/2026 at 18:16, 1 hour 53 minutes ago

    Kaufman & Broad SA: 2026 FIRST HALF RESULTS

View all EQS
Les Echos
  • Published on 07/08/2026 at 18:30, 1 hour 40 minutes ago

    Suspension of the liquidity contract

  • Published on 07/08/2026 at 18:00, 2 hours 10 minutes ago

    €464 MILLION OF NEW FINANCING TO SUPPORT FREY'S GROWTH

  • Published on 07/08/2026 at 17:45, 2 hours 25 minutes ago

    Half-year liquidity contract statement of ALTEN SA as at 30 June 2026

  • Published on 07/08/2026 at 17:40, 2 hours 30 minutes ago

    Report on share repurchases from 1 to 7 July 2026

  • Published on 07/08/2026 at 11:15, 8 hours 55 minutes ago

    Half-year statement of the liquidity contract H1 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy